Clinical trial
Evaluation of the Effects of Duloxetine on Norepinephrine
NCT00414323 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00414323 |
|---|---|
| Title | Evaluation of the Effects of Duloxetine on Norepinephrine |
| Official title | Evaluation of the Effects of Duloxetine on Norepinephrine Transporter Inhibition in Healthy Subjects |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Duloxetine, Escitalopram, Placebo |
| Enrollment | 35 |
| Start date | Nov 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Dec 21, 2006 |
| Last update posted | Jun 12, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: